Clinical Trial

A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

Name: A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients — clinical trial record (NCT07036419)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2/3

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.

Protocol Amendment History 1 change

critical Trial completed 2026-06-05

Trial Details

NCT Number	NCT07036419
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients
Enrollment	249 participants
Start Date	2025-07-10
Primary Completion	2026-05-27 (estimated)
Study Completion	2026-05-27 (estimated)
Updated on ClinicalTrials.gov	2026-06-04